Date, Price, GMP, Review, and Details of the Global Health IPO
Located in the northern and eastern parts of India, Global Health Limited is a leading private multi-specialty tertiary care provider.
In addition to its core competencies in cardiology and cardiac science, neuroscience, oncology, digestive and hepatobiliary sciences, orthopedics, liver transplantation, and urology, the company has established itself as a leader in the fields of liver transplantation and kidney and urology.
The “Medanta” trademark is used by four hospitals run by Global Health Limited in India (in the cities of Gurugram, Indore, Ranchi, and Lucknow). When it comes to biomarkers and other tissue-based research, the company set up “The Medanta Institutional Tissue Repository” in 2017.
Healthcare service revenue for the years ending June 30, 2020, 2021, and 2022 was Rs. 14,805.71 billion, Rs. 14,178.41 billion, Rs. 21,003.95 billion, Rs. 4,732.10 billion, and Rs. 5,960.89 226 billion, while EBITDA was Rs. 2,304.54 billion, Rs. 2,228.52 billion, Rs. 4,897.57 billion, Rs. 1,057.69 billion, and Rs. 1,416.46 billion.
The company’s hospitals, which span a combined 4.7 million square feet and have 2,467 installed beds as of June 30, 2022, provide healthcare services in more than 30 medical specialties and employ more than 1,300 doctors under the direction of seasoned department heads.
The Gurugram hospital owned by Global Health Limited has been named the best private hospital in India for three years running (2020, 2021, and 2022) by Newsweek. In addition, in 2021 it was the only Indian private hospital to make Newsweek’s list of the top 200 global hospitals, and in 2022 it was one of only 250.
Advantages in the Market
- The country’s preeminent provider of tertiary and quaternary care, especially for complex situations.
Academics and Medical Research Should Be Priorities. - Institutions of a massive scale that boast state-of-the-art facilities and cutting-edge medical technology and equipment.
- Successful track record in business and finances.
- Pay special attention to high-population, low-service areas found in major state capitals (NCR, Lucknow, and Patna).
- Possibilities for expansion of present infrastructure as well as the development of supplementary services, such as digital health.
Management staff at the top is highly competent, and they have the backing of the stock market.
Company Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Net Worth | Total Borrowing |
|---|---|---|---|---|---|
| 31-Mar-20 | 2666.29 | 1544.27 | 36.33 | 1349.54 | 621.94 |
| 30-Jun-20 | 2855.11 | 491.58 | 41.76 | 1425.38 | 725.07 |
| 31-Mar-21 | 2694.1 | 1478.16 | 28.8 | 1382.34 | 644.6 |
| 31-Mar-22 | 3145.52 | 2205.82 | 196.2 | 1616.01 | 837.86 |
| 30-Jun-22 | 3221.94 | 626.54 | 58.71 | 1675.55 | 794.45 |
| Amount in ₹ Crore | |||||
Goals of the Debate
The company plans to use the money from the net sales of the Fresh Issue to pay for the following things:
1. Repayment or early payment of loans taken out by GHPPL and MHPL’s subsidiaries, in full or in part.
2. General corporate purposes.
Global Health IPO Details
| IPO Date | Nov 3, 2022 to Nov 7, 2022 |
| Listing Date | Wednesday, November 16, 2022 |
| Face Value | ₹2 per share |
| Price | ₹319 to ₹336 per share |
| Lot Size | 44 Shares |
| Issue Size | [.] shares of ₹2 (aggregating up to ₹2,205.57 Cr) |
| Fresh Issue | [.] shares of ₹2 (aggregating up to ₹500.00 Cr) |
| Offer for Sale | 50,761,000 shares of ₹2 (aggregating up to ₹1,705.57 Cr) |
| Issue Type | Book Built Issue IPO |
| Listing At | BSE, NSE |
| QIB Shares Offered | Not more than 50% of the Offer |
| NII (HNI) Shares Offered | Not less than 15% of the Offer |
| Retail Shares Offered | Not less than 35% of the Offer |
| Company Promoters | Dr. Naresh Trehan is the company promoter. |
Possible Schedule for the Global Health IPO
The IPO for Global Health starts on November 3, 2022, and ends on November 7, 2022. The bid date for the Global Health IPO is from November 3, 2022 at 10 a.m. to November 7, 2022 at 5 p.m. The last time to confirm a UPI Mandate is at 5 p.m. on the day the issue ends.
| Event | Tentative Date |
|---|---|
| Opening Date | Nov 3, 2022 |
| Closing Date | Nov 7, 2022 |
| Basis of Allotment | Nov 11, 2022 |
| Initiation of Refunds | Nov 14, 2022 |
| Credit of Shares to Demat | Nov 15, 2022 |
| Listing Date | Nov 16, 2022 |
Global Health IPO Lot Size
The Global Health IPO lot size is 44 shares. A retail-individual investor can apply for up to 13 lots (572 shares or ₹192,192).
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 1 | 44 | ₹14,784 |
| Retail (Max) | 13 | 572 | ₹192,192 |
| S-HNI (Min) | 14 | 616 | ₹206,976 |
| B-HNI (Min) | 68 | 2,992 | ₹1,005,312 |
Global Health IPO Promoter Holding
| Pre Issue Share Holding | 35% |
| Post Issue Share Holding | 33% |
Global Health IPO Status of Sign-ups (Bidding Detail)
At 7 p.m. on November 7, 2022, 9.58 people have signed up for the Global Health IPO.
The public offering was bought out 0.88 times by retail investors, 28.64 times by QIB investors, and 4.02 times by NII investors. Check the details of your Day by Day subscription (Live Status)
| Category | Subscription (times) |
|---|---|
| QIB | 28.64 |
| NII | 4.02 |
| bNII (bids above ₹10L) | 5.16 |
| sNII (bids below ₹10L) | 1.73 |
| Retail | 0.88 |
| Total | 9.58 |
Global Health IPO Listing Date
| Listing Date | Wednesday, November 16, 2022 |
| BSE Script Code | 543654 |
| NSE Symbol | MEDANTA |
| Listing In | B Group of Securities |
| ISIN | INE474Q01031 |
| IPO Price | ₹336 per share |
| Face Value | ₹2 per share |
Company Contact Information
Medanta – Mediclinic,
E-18, Defence Colony,
New Delhi, Delhi 110 024,
Phone: +91 124 483 4060
Email: compliance@medanta.org
Website: https://www.medanta.org/
FAQs on the Global Health IPO
What does IPO stand for?
Global Health IPO is a main-board IPO of equity shares with a face value of 2, which adds up to 2,205.57 Crores. The price per share is between 319 and 336. The least you can order is 44 Shares.
The IPO starts trading on November 3, 2022, and ends on November 7, 2022.
The IPO is being signed up for by KFin Technologies Limited. It is planned to list the shares on the BSE and NSE.
How do I use Zerodha to apply for the Global Health IPO?
Customers of Zerodha can apply online for the Global Health IPO and pay with UPI. Customers of Zerodha can apply for the Global Health IPO by logging in to their back office, or Zerodha Console, and filling out an IPO application form.
How to apply through Zerodha for the Global Health IPO
- Log in to Console on the Zerodha website.
- Click the IPOs link on the Portfolio page.
- Click the “Bid” button next to the “Global Health IPO” row.
- Type in your UPI ID, the amount, and the price.
- “Send in” your IPO application form.
- To approve the mandate, go to the UPI App (net banking or BHIM).
- Go to Review of the Zerodha IPO Application Process for more information.
When will the Global Health IPO start?
The IPO for Global Health starts on November 3, 2022, and ends on November 7, 2022.
How do you sign up for the Global Health IPO?
You can use either UPI or ASBA to pay for an online application to Global Health IPO. Your bank account’s online banking is where you can find the ASBA IPO application. Brokers offer the UPI IPO application, but they don’t do banking. Find out more about how to apply for an initial public offering (IPO) online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank, and SBI Bank.
When will Global Health go public?
The Basis of Allotment for the Global Health IPO will be finalised on November 11, 2022, and your demat account will be credited with the allotted shares by November 15, 2022. Check on the status of the Global Health IPO allotment.
When is the IPO date for Global Health?
The IPO listing date for Global Health is Wednesday, November 16, 2022.
